Squarepoint Ops LLC Regeneron Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 41,100 shares of REGN stock, worth $28.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

41,100

Previous 13,700 200.0%

Holding current value

$28.8 Million

Previous $14.4 Million 200.06%

% of portfolio

0.07%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $39.1 Million - $45.9 Million	38,226 Added 1330.06%	41,100 $43.2 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $2.12 Million - $2.57 Million	-2,397 Reduced 45.48%	2,874 $3.02 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $34.2 Million - $37.6 Million	-37,892 Reduced 87.79%	5,271 $5.07 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $30.3 Million - $34.4 Million	39,028 Added 943.85%	43,163 $37.9 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $9.38 Million - $11.1 Million	-13,402 Reduced 76.42%	4,135 $2.97 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $11.4 Million - $13.8 Million	16,737 Added 2092.13%	17,537 $14.4 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $564,712 - $613,112	800 New	800 $577,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $8.18 Million - $10.1 Million	-15,060 Reduced 36.74%	25,927 $16.4 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $20.4 Million - $24.2 Million	35,504 Added 647.53%	40,987 $24.8 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $17.5 Million - $20.7 Million	-37,009 Reduced 87.1%	5,483 $3.06 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $5.12 Million - $6.28 Million	11,451 Added 36.89%	42,492 $20.1 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $10.3 Million - $13.1 Million	21,587 Added 228.34%	31,041 $15 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $5.15 Million - $6.22 Million	9,454 New	9,454 $5.29 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $4.53 Million - $5.91 Million	-9,185 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $3.09 Million - $4.54 Million	9,185 New	9,185 $4.49 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $14.5 Million - $19.9 Million	-52,787 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $1.31 Million - $1.53 Million	-4,799 Reduced 8.33%	52,787 $14.6 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $2.75 Million - $3.8 Million	9,171 Added 18.94%	57,586 $18 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $18 Million - $21.3 Million	48,415 New	48,415 $19.9 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $3.13 Million - $3.79 Million	-11,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $1.7 Million - $2.12 Million	5,377 Added 95.63%	11,000 $3.79 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $12.7 Million - $16.6 Million	-35,422 Reduced 86.3%	5,623 $2.11 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $17.7 Million - $20.7 Million	41,045	41,045 $18.4 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Regeneron Pharmaceuticals, Inc. Transaction History